PETROS PHARMACEUTICALS INC (PTPI)
US71678J2096 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.16M | -20.04M | -8.99M | -20.59M | -32.51M | |||
| Depreciation Amortization | 3.28M | 5.60M | 6.88M | 6.66M | 5.29M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | -1.43M | -650.00K | |||
| Change In Working Capital | 624.91K | -3.09M | -1.69M | -5.60M | 13.07M | |||
| Interest Paid | 536.14K | 600.00K | 420.00K | 1.19M | 2.04M | |||
| Other non cash items | -3.37M | 4.73M | -8.06M | 5.65M | 17.33M | |||
| OPERATING CASH FLOW | -7.63M | -12.80M | -11.86M | -15.31M | 2.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | 0.00 | -70.00K | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | 0.00 | -70.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.46M | -1.62M | -7.19M | 8.78M | -6.01M | |||
| Stock Issued/Repurchased | 13.00M | 0.00 | 25.76M | 20.00K | 2.90M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 21.50M | N/A | |||
| FINANCING CASH FLOW | 11.54M | -1.62M | 18.57M | 30.30M | -3.11M | |||
| CHANGE IN CASH | 3.91M | -14.42M | 6.71M | 14.99M | -650.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.63M | -12.80M | -11.86M | -15.31M | 2.53M | |||
| Capital Expenditure | N/A | N/A | 0.00 | 0.00 | -70.00K | |||
| FREE CASH FLOW | -7.63M | -12.80M | -11.86M | -15.31M | 2.46M | |||
All data in USD